Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Its approved for Wegovy pill weight loss and cardiovascular risk reduction in adults with obesity or overweight
Another cost-effectiveness analysis published in JMCP found that tirzepatide 15 mg produced greater quality-adjusted life-years (QALYs) and delayed progression to insulin, with incremental cost-effectiveness ratios (ICERs) of about USD 54,700/QALY (15 mg) and USD 70,100/QALY (10 mg) vs semaglutide 2.0 mg
PMID: 30112787 Hindley RG et al (2004): Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity
Visit our Medical Weight Loss Program page or book a free consultation today
This includes assessment of insulin sensitivity, fasting blood sugar and A1C, inflammatory markers, gut health status, body composition, and hormonal balance
US$ 21.99
US$ 29.36
US$ 20.33
US$ 20.11
US$ 20.37
